COMP <GO>
ASST vs BAC // RSI-14 & 200D SMA MOMENTUM
Strive Inc. (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: ASST 8
— BAC 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ASST
LAST: $22.20 (-10.88%) • MKT CAP: $3.17B
rsi-technicals
36.7
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
rsi-technicals
27.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASST VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASST | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.80% | 2.50% | +16.30 | ASST | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.7x | 30.2x | -10.50 | ASST | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.10% | +0.11 | ASST | /fcf-yield <GO> |
| Operating Margin | 13.90% | 32.90% | -19.00 | BAC | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 27.00% | -16.10 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 6.80% | +173.20 | ASST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 0.45 | +25.55 | ASST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | ASST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.60% | -0.10 | ASST | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 36.7 | 27.7 | +9.04 | ASST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.90 | -0.01 | BAC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 10.9x | +16.70 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.17B | $357.61B | -$354.44B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASST REV | BAC REV | ASST GROSS % | BAC GROSS % | ASST FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $113.10B | — | 44.0% | $0 | $7.52B |
| FY 2024 | $3.6M | $105.86B | 44.0% | 44.0% | -$21.6M | -$13.57B |
| FY 2023 | $277.0K | $102.77B | 44.0% | 44.0% | -$3.8M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASST // BETA 0.89
BAC // BETA 0.90